2 terminated, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Biological: new trials by email Literature Review of Biological trials Research Report on Biological
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A Gene therapy, Biological - Hemophilia A | Phase 1 | Not yet recruiting | Expression Therapeutics, LLC | 7 | 2024-09-01 | 2024-02-20 |
| Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors Biological - Refractory/Relapse Neuroblastoma, Pediatric Solid Tumors | Phase 1 | Recruiting | Kyushu University | 61 | 2022-10-26 | 2026-08-07 |
| Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC Biological - Cell Therapy, NSCLC | Phase 1 / Phase 2 | Terminated | GAIA BioMedicine Inc. | 22 | 2021-12-01 | 2026-09-03 |
| A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. NZV930, PDR001, NIR178 - Non-small Cell Lung Cancer (NSCLC), Triple Negative Breast Cancer (TNBC) | Phase 1 | Terminated | Novartis Pharmaceuticals | 127 | 2018-07-18 | 2024-12-13 |
| Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy Biological - Treatment of Type I Diabetes Mellitus. | Phase 1 / Phase 2 | Unknown | DiaVacs, Inc. | 90 | 2013-10-01 | 2013-10-23 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Hemophilia A (1) · Ovarian Neoplasms (1) · Triple Negative Breast Neoplasms (1)
DiaVacs, Inc. (1) · Expression Therapeutics, LLC (1) · GAIA BioMedicine Inc. (1) · Kyushu University (1) · Novartis Pharmaceuticals (1)
Japan (3) · United States (2) · Australia (1) · Canada (1) · Singapore (1) · Spain (1) · United Kingdom (1)
Yoshikazu Yonemitsu, MD, PhD (1)
2018 (1)